JEFFREY W. SHERMAN

Insider Reports History

Location
Irvine, CA
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JEFFREY W. SHERMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 214,380 $1,665,732 $7.77 04 Jun 2025 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 5,400 $41,958 $7.77 04 Jun 2025 By: JEFFREY W SHERMAN LIVING TRUST U/A DTD 03/21/2001
Larimar Therapeutics, Inc. Director Stock Option (Right to Buy) 19,000 13 May 2025 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Restricted Stock Units (RSUs) 12,696 05 Jan 2023 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Performance Restricted Stock Units (PSUs) 4,654 05 Jan 2023 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Ordinary Shares 0 $116.50 06 Oct 2023 By Spouse
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Ordinary Shares 0 $116.50 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Ordinary Shares 0 $116.50 06 Oct 2023 Indirect
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Performance Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP and Chief Medical Officer Stock Option (Right to Buy) 0 06 Oct 2023 Direct
Strongbridge Biopharma plc Director Ordinary Shares 0 $2.06 05 Oct 2021 Direct
Strongbridge Biopharma plc Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct
Xeris Biopharma Holdings, Inc. Director Stock Option (Right to Buy) 0 28 Aug 2025 Direct
XERIS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by JEFFREY W. SHERMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 28 Aug 2025 3 -$21,229 4 Director 29 Aug 2025, 17:21
XERS Xeris Biopharma Holdings, Inc. 04 Jun 2025 1 $0 4 Director 04 Jun 2025, 19:02
LRMR Larimar Therapeutics, Inc. 13 May 2025 1 $0 4 Director 14 May 2025, 16:34
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:19
LRMR Larimar Therapeutics, Inc. 29 May 2024 1 $0 4 Director 31 May 2024, 16:57
XERS Xeris Biopharma Holdings, Inc. 15 Mar 2024 1 $0 4 Director 11 Apr 2024, 16:05
XERS Xeris Biopharma Holdings, Inc. 27 Nov 2023 1 +$10,098 4 Director 29 Nov 2023, 16:09
/report/000120919123052358-sherman-jeffrey-w-2023-10-06 Horizon Therapeutics Public Ltd Co 06 Oct 2023 17 -$27,349,424 4 EVP and Chief Medical Officer 06 Oct 2023, 17:48
LRMR Larimar Therapeutics, Inc. 03 Oct 2023 1 $0 4 Director 05 Oct 2023, 16:33
LRMR Larimar Therapeutics, Inc. 03 Oct 2023 0 $0 3 Director 05 Oct 2023, 16:32
/report/000120919123048609-sherman-jeffrey-w-2023-09-06 Horizon Therapeutics Public Ltd Co 06 Sep 2023 1 $0 4 EVP and Chief Medical Officer 07 Sep 2023, 17:15
XERS Xeris Biopharma Holdings, Inc. 07 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:52
/report/000120919123003738-sherman-jeffrey-w-2023-01-17 Horizon Therapeutics Public Ltd Co 17 Jan 2023 2 $0 4 EVP and Chief Medical Officer 18 Jan 2023, 15:21
/report/000120919123003146-sherman-jeffrey-w-2023-01-10 Horizon Therapeutics Public Ltd Co 10 Jan 2023 2 -$761,673 4 EVP and Chief Medical Officer 12 Jan 2023, 15:29
/report/000120919123002439-sherman-jeffrey-w-2023-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2023 11 -$3,153,087 4 EVP and Chief Medical Officer 06 Jan 2023, 16:54
/report/000120919123000939-sherman-jeffrey-w-2023-01-01 Horizon Therapeutics Public Ltd Co 01 Jan 2023 3 -$1,105,795 4 EVP and Chief Medical Officer 04 Jan 2023, 15:27
/report/000120919122062917-sherman-jeffrey-w-2022-12-27 Horizon Therapeutics Public Ltd Co 27 Dec 2022 2 $0 4 EVP and Chief Medical Officer 29 Dec 2022, 15:31
/report/000120919122060901-sherman-jeffrey-w-2022-12-12 Horizon Therapeutics Public Ltd Co 12 Dec 2022 4 -$3,159,692 4 EVP and Chief Medical Officer 13 Dec 2022, 15:12
XERS Xeris Biopharma Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:15
/report/000120919122023841-sherman-jeffrey-w-2022-04-06 Horizon Therapeutics Public Ltd Co 06 Apr 2022 1 -$4,621,872 4 EVP and Chief Medical Officer 08 Apr 2022, 16:07
/report/000120919122020259-sherman-jeffrey-w-2022-03-18 Horizon Therapeutics Public Ltd Co 18 Mar 2022 8 +$188,876 4 EVP and Chief Medical Officer 21 Mar 2022, 16:25
/report/000120919122004632-sherman-jeffrey-w-2022-01-21 Horizon Therapeutics Public Ltd Co 21 Jan 2022 3 -$204,988 4 EVP and Chief Medical Officer 24 Jan 2022, 16:05
/report/000120919122002285-sherman-jeffrey-w-2022-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2022 12 $0 4 EVP and Chief Medical Officer 06 Jan 2022, 19:57
/report/000120919121062085-sherman-jeffrey-w-2021-10-27 Horizon Therapeutics Public Ltd Co 27 Oct 2021 2 +$81,648 4 EVP and Chief Medical Officer 29 Oct 2021, 16:55
/report/000117911021009279-sherman-jeffrey-w-2021-10-05 Strongbridge Biopharma plc 05 Oct 2021 2 $0 4 Director 06 Oct 2021, 19:41
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 8 $0 4 Director 05 Oct 2021, 19:41
/report/000089924321039259-sherman-jeffrey-w-2021-10-05 XERIS PHARMACEUTICALS INC 05 Oct 2021 4 $0 4 Director 05 Oct 2021, 17:38
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 17:21
/report/000117911021009221-sherman-jeffrey-w-2021-10-01 Strongbridge Biopharma plc 01 Oct 2021 1 -$36,592 4 Director 05 Oct 2021, 19:23
/report/000120919121057450-sherman-jeffrey-w-2021-09-21 Horizon Therapeutics Public Ltd Co 21 Sep 2021 5 -$4,737,688 4 EVP and Chief Medical Officer 23 Sep 2021, 17:00
/report/000120919121048791-sherman-jeffrey-w-2021-07-28 Horizon Therapeutics Public Ltd Co 28 Jul 2021 3 -$329,538 4 EVP and Chief Medical Officer 30 Jul 2021, 16:27
/report/000120919121045065-sherman-jeffrey-w-2021-07-01 Horizon Therapeutics Public Ltd Co 01 Jul 2021 4 -$5,707,362 4 EVP and Chief Medical Officer 02 Jul 2021, 17:02
/report/000134630221000061-sherman-jeffrey-w-2021-06-08 XERIS PHARMACEUTICALS INC 08 Jun 2021 1 $0 4 Director 08 Jun 2021, 19:10
/report/000117911021005557-sherman-jeffrey-w-2021-05-18 Strongbridge Biopharma plc 18 May 2021 1 $0 4 Director 18 May 2021, 19:12
/report/000117911021005442-sherman-jeffrey-w-2021-05-14 Strongbridge Biopharma plc 14 May 2021 1 -$44,518 4 Director 17 May 2021, 18:31